Etamep 1 g LYOPHILISED POWDER FOR SOLUTION FOR INJECTION
PDF Leaflet Revision Date: 17 March 2020
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of moderate to severe infections caused by susceptible bacteria.
Dosage (summary)
Adults: 1 g IV/IM once daily; Pediatrics: 15 mg/kg twice daily (max 1 g/day).
Onset of Action / Duration
Onset: 2 hours, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; excreted in breast milk.
Key Drug Interactions
- Probenecid increases plasma concentrations
- Decreased serum levels of valproic acid
Contraindications
- Hypersensitivity to ertapenem or beta-lactams
- Bacterial meningitis
- Severe shock or heart block
Common side effects
- Allergic reactions
- Headache
- Seizures
- Diarrhea
- Nausea
Counselling Points
- Monitor for allergic reactions
- Avoid driving until effects are known
- Complete the full course of therapy
Serious warnings
- Serious hypersensitivity reactions
- Pseudomembranous colitis
- Seizures in predisposed patients
Important Disclaimer
The Etamep 1 g LYOPHILISED POWDER FOR SOLUTION FOR INJECTION professional information leaflet below is the property of Aurobindo Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
